Apo-Methylphenidate ER 36 mg (Methylphenidate Hydrochloride TABLET (EXTENDED-RELEASE)) 36 MG

APO-METHYLPHENIDATE ER 36 MG is an extended-release tablet containing methylphenidate hydrochloride. It is commonly used to manage certain conditions related to focus and attention. This medication is designed for oral administration and is manufactured by Apotex Inc. in Canada.

Strength

36 MG

Pack Size

100

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-METHYLPENIDATE ER 36 MG is primarily used to help improve focus and attention in individuals with certain conditions. It is often prescribed for managing symptoms related to attention deficit disorders. The extended-release formulation is designed to provide a steady release of the active ingredient over time, which may help maintain consistent levels in the body.

Side Effects

Common effects of APO-METHYLPHENIDATE ER 36 MG may include increased alertness and improved concentration. Some individuals may experience changes in appetite or sleep patterns. It is important to note that effects can vary from person to person, and not everyone will experience the same outcomes.

Precautions & Warnings

APO-METHYLPHENIDATE ER 36 MG should be handled with care and stored as directed. It is important to follow the guidance of a healthcare provider regarding its use. This medication should not be shared with others, even if they have similar symptoms. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

APO-METHYLPHENIDATE ER 36 MG may interact with certain substances, including alcohol and other medications that affect the central nervous system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare provider regarding the use of this medication.

Frequently Asked Questions

APO-METHYLPHENIDATE ER 36 MG is used to help improve focus and attention in individuals with certain conditions related to attention deficit disorders.

APO-METHYLPHENIDATE ER 36 MG is designed for oral administration. It is important to follow the specific instructions provided by your healthcare provider.

Common effects may include increased alertness and improved concentration. Some individuals may experience changes in appetite or sleep patterns.

APO-METHYLPHENIDATE ER 36 MG may interact with certain medications. It is important to inform your healthcare provider about all medications you are taking.

APO-METHYLPHENIDATE ER 36 MG should be handled with care and stored as directed. Always consult a healthcare provider before starting or stopping any medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.